Integrated BioPharma, Inc. (INBP)
0.189
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Integrated BioPharma Free Cash Flow : 0.895M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.895M |
| March 31, 2026 | 2.825M |
| December 31, 2025 | 2.808M |
| September 30, 2025 | 2.387M |
| June 30, 2025 | 1.86M |
| March 31, 2025 | 0.941M |
| December 31, 2024 | 1.739M |
| September 30, 2024 | -0.284M |
| June 30, 2024 | 0.39M |
| March 31, 2024 | -0.482M |
| December 31, 2023 | -0.326M |
| September 30, 2023 | 1.449M |
| June 30, 2023 | 1.116M |
| March 31, 2023 | 4.988M |
| December 31, 2022 | 4.066M |
| September 30, 2022 | 2.577M |
| June 30, 2022 | 3.605M |
| March 31, 2022 | 1.504M |
| December 31, 2021 | 2.113M |
| September 30, 2021 | 2.86M |
| June 30, 2021 | 2.755M |
| March 31, 2021 | -0.078M |
| December 31, 2020 | 1.215M |
| September 30, 2020 | 1.363M |
| June 30, 2020 | 1.125M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.954M |
| December 31, 2019 | 2.072M |
| September 30, 2019 | 0.966M |
| June 30, 2019 | -0.086M |
| March 31, 2019 | -0.855M |
| December 31, 2018 | -0.71M |
| September 30, 2018 | -0.001M |
| June 30, 2018 | 0.921M |
| March 31, 2018 | 0.292M |
| December 31, 2017 | 0.036M |
| September 30, 2017 | 2.134M |
| June 30, 2017 | 0.07M |
| March 31, 2017 | 1.059M |
| December 31, 2016 | 0.957M |
| September 30, 2016 | -1.665M |
| June 30, 2016 | -0.703M |
| March 31, 2016 | -1.022M |
| December 31, 2015 | 0.114M |
| September 30, 2015 | 0.71M |
| June 30, 2015 | -0.348M |
| March 31, 2015 | -0.47M |
| December 31, 2014 | -0.934M |
| September 30, 2014 | 0.265M |
| June 30, 2014 | 1.695M |
| March 31, 2014 | 1.393M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Medifast, Inc. | 4.013M |
| BioForce Nanosciences Holdings, Inc. | -0.0419M |
| Skinvisible, Inc. | 0.0038M |
| SkyTech Orion Global Corp. | -0.685M |
| Nevis Brands, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.194M |
| Cash from Investing (Quarterly) | -0.149M |
| Cash from Financing (Quarterly) | -0.012M |
| Free Cash Flow Per Share (Quarterly) | -0.0432 |
| Free Cash Flow to Equity (Quarterly) | -1.075M |
| Free Cash Flow to Firm (Quarterly) | -1.343M |
| Free Cash Flow Yield | 15.20% |